Glutamate weighted imaging contrast in gliomas with 7 Tesla magnetic resonance imaging

INTRODUCTION: Diffuse gliomas are incurable malignancies, which undergo inevitable progression and are associated with seizure in 50–90% of cases. Glutamate has the potential to be an important glioma biomarker of survival and local epileptogenicity if it can be accurately quantified noninvasively....

Descripción completa

Detalles Bibliográficos
Autores principales: Neal, Andrew, Moffat, Bradford A., Stein, Joel M., Nanga, Ravi Prakash Reddy, Desmond, Patricia, Shinohara, Russell T., Hariharan, Hari, Glarin, Rebecca, Drummond, Katharine, Morokoff, Andrew, Kwan, Patrick, Reddy, Ravinder, O'Brien, Terence J., Davis, Kathryn A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6396013/
https://www.ncbi.nlm.nih.gov/pubmed/30822716
http://dx.doi.org/10.1016/j.nicl.2019.101694

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6396013/
https://www.ncbi.nlm.nih.gov/pubmed/30822716
http://dx.doi.org/10.1016/j.nicl.2019.101694

Ejemplares similares